The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1201-1210

  Yang, Xiaotong ^a   Sit, Wai Hung ^a   Chan, Daniel Kwong On ^a   Wan, Jennifer Man Fan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Bcl 2 and Bax; Caspase; Mitochondrial membrane potential; Polysaccharide peptide

Indexed keywords

BAX PROTEIN, HUMAN; CASPASE; CYTOCHROME C; POLYSACCHARIDE PEPTIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEOGLYCAN;

APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CELL STRAIN HL 60; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; MITOCHONDRION; T LYMPHOCYTE;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CYTOCHROMES C; ENZYME ACTIVATION; HL-60 CELLS; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTES;

EID: 24744432974     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1201     Document Type: Article

References (53)

1. Reed JC: Bcl-2 family of protein. Oncogene 17: 3225-3236, 1998.
2. Alnemri ES: Hidden powers of the mitochondria. Nat Cell Biol 1:40-42, 1999.
3. Petit PX, Goubern M, Diolez P, Susin SA, Zamzani N and Kroemer G: Disruption of the outer mitochondrial membrane as a result of large swelling: the impact of irreversible permeability transition. FEBS Lett 426: 111-116, 1998. (Pubitemid 28198166)
4. Marchetti P, Castedo M, Susin SA, Zamzani N, Hirsch T, Haefner A, et al: Metochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184: 1155-1160,1996. (Pubitemid 26313572)
5. Li P, Nijhawan D and Budihardjo I: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997. (Pubitemid 27508237)
6. Xia T, Jiang C, Li L, Wu C, Chen Q and Liu S: A study on permeability transition pore opening and cytochrome c release from mitochondria, induced by caspase- 3 in vitro. FEBS Lett 510: 62-66, 2002. (Pubitemid 34084885)
7. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999. (Pubitemid 32250377)
8. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, et al: Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22: 1633-1639, 2001.
9. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1997. (Pubitemid 28391864)
10. Gamen S, Anel A, Lasierra P, Alava MA, Martinez-Lorenzo MJ, Pineiro A, et al: Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way. FEBS Lett 417: 360-364, 1997. (Pubitemid 27511623)
11. Oltvai ZN, Milliman CL and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
12. Manon S, Chauduri B and Guerin M: Release of cytochrome c and decrease of cytochrome d oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-2-xL. FEBS Lett 415: 29-32, 1977.
13. Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB and Cohen C: Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Cytometry (Clinical Cytometry) 50: 203-209, 2002.
14. Toh HC, Sun L, Koh CH and Aw SE: Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: a comparison with vincristine. Leuk Lymphoma 31: 195-208, 1998. (Pubitemid 28428763)
15. Plosker GL and Figgitt DP: Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 63: 803-843, 2003. (Pubitemid 36432084)
16. Harrison DJ: Molecular mechanisms of drug resistance in tumours. J Pathol 175: 7-12, 1995.
17. Desoize B: Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 14: 2291-2294, 1994.
18. Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5: 4-27, 2000.
19. Ooi VE and Liu F: hnmunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7: 715-729, 2000. (Pubitemid 30366638)
20. Ng TB: A review of research on the protein-bound polysaccharide (Polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes:Polyporaceae). Gen Pharmac 30: 1-4, 1998.
21. Hsieh TC, Kunicki J, Darzynkiewicz Z and Wu JM: Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta,-6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. J Altern Complement Med 8: 591-602, 2002. (Pubitemid 35291594)
22. Mao XW, Archambeau JO and Gridley DS: Immunotherapy with low-dose interleukin-2 and a Polysaccharopeptide derived from Coriolus versicolor. Cancer Biother Radiopharm 11: 393-403,1996. (Pubitemid 27016419)
23. Liu WK, Ng TB, Sze SF and Tsui KW: Activation of peritoneal macrophages by polysaccharopeptide from the mushroom, Coriolus versicolor. Immunopharmacology 26: 139-146, 1993. (Pubitemid 23280760)
24. Qian ZM, Xu MF and Tang PL: Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. Am J Clin Med 25: 27-35, 1997. (Pubitemid 127757846)
25. Mao XW, Green LM and Gridley DS: Evaluation of polysaccharopeptide effects against C6 glioma in combination with radiation. Oncology 61: 243-253, 2001. (Pubitemid 34701540)
26. Yang QY, Jong SC, Li XY, Zhou JX, Chen RT and Xu LZ: Antitumor and immunomodulating activities of the polysaccharide-peptide (PSP) of Coriolus versicolor. J Immunol Immunopharmacol 12: 29-34, 1992.
27. Chow LW, Lo CS, Loo WT, Hu XC and Sham JS: Polysaccharide peptide mediates apoptosis by regulating p21 gene and down-regulating cyclin Dl gene. Am J Chin Med 31: 1-9, 2003. (Pubitemid 41758855)
28. Wyllie AH, Kerr JF and Currie AR: Cell death: the significance of apoptosis. IntRev Cytol 68: 251-306, 1980. (Pubitemid 11219226)
29. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T and Traganos F: Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27: 1-20, 1997. (Pubitemid 27059777)
30. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1997.
31. Lee CYJ and Wan JM: Immunoregulatory and antioxidant performance of alpha-tocopherol and selenium on human lymphocytes. Biol Trace Elem Res 86: 123-135, 2002.
32. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST and van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39-51,1995.
33. Chiu LCM and Wan JM: Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with down-regulation of bcl-2 expression. Cancer Lett 145: 17-27, 1999. (Pubitemid 29459065)
34. Macho A, Decaudin D, Castedo M, Hirsch T, Susin SA, Zamzami N, et a: Chloromethyl-X-Rosamine is an aldehydefixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 25: 333-340, 1996.
35. Martinou JC, Desagher S and Antonsson B: Cytochrome c release from mitochondria: all or nothing. Nat Cell Biol 2: 41-43, 2000.
36. Bedner E, Smolewski P, Amstad P and Darzynkiewicz Z: Activation of caspases measured in situ by binding of fluoro-chrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res 260: 308-313, 2000.
37. Liang ZQ, Sheng WH and Wang XX: Regulatory effect of polysaccharopeptide on human peripheral blood lymphocyte proliferation and T lymphocyte subpopulation. Traditional Chin Med 30: 37-38, 1999.
38. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, et at FLICE, a novel FADD-homologus ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.
39. Zou H, Henzel WJ, Liu X, Lutschq A and Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997. (Pubitemid 27347231)
40. Li H, Zhu H and Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1997. (Pubitemid 28391865)
41. Shiu WCT, Leung TWT and Tao M: A clinical study of PSP on peripheral blood counts during chemotherapy. Phytother Res 6: 217-218, 1992.
42. Shi JH, Chan T and Lian ZR: The clinical research of the effect of PSP on the immunological function of stomach cancer patients during operation and chemotherapy. In: PSP International Symposium. Yang QY and Kwok CY (eds). Shanghai: Fudan University Press, pp232-240, 1993.
43. Dong Y, Kwan CY, Chen ZN and Yang MM: Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor, in vitro and in vivo studies. Res Commun Mol Pathol Pharmacol 92: 219-224, 1996.
44. Li X, Du L and Darzynkiewicz Z: During apoptosis of HL-60 and U-937 cells caspases are activated independently of dissipation of mitochondrial electrochemical potential. Exp Cell Res 257: 290-297, 2000. (Pubitemid 30390480)
45. Wissing D, Mouritzen H and Jaattela M: TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Radical Biol Med 25: 57-65, 1998. (Pubitemid 28285271)
46. Fincane DM, Waterhouse NJ, Amarante-Mendes GP, Cotter T and Green DG: Collapse of the inner mitochondrial transmembrane potential is not required for apoptosis of HL60 cells. Exp Cell Res 251: 166-174, 1999. (Pubitemid 29406530)
47. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM and Kroemer G: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
48. Cai J and Jones DP: Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273: 11401-11404, 1998. (Pubitemid 28272028)
49. King MA and Radicchi-Mastroianni MA: Effects of Caspase inhibition on camptothecin-induced apoptosis of HL-60 cells. Cytometry 49: 28-35, 2002. (Pubitemid 41200821)
50. Sane AT and Bertrand R: Caspase inhibition in camptothecin-treated U-973 cells is couple with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res 59:3565-3569, 1999.
51. Vander Heiden MG and Thompson CB: Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:209-216, 1999.
52. Kuida K, Zheng TS, Kuan C and Yang D: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372, 1996. (Pubitemid 26408520)
53. Nichoslon DW, Ali A, Thornberry NA and Vaillancourt JP: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.